Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2023First federal award
$1.5MFederal grants as PI2 awards
0Patents grantedNone matched
361Papers22,776 citations
Federal awards and patents by year
AwardsPatents
2 awards · $1.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 17, 2026 | NIH | STTR Phase II Targeting EGFR-Mutant NSCLC CNS Metastases with CM93, a Novel Brain-Penetrant EGFR Inhibitor | $1.1M | CRIMSON BIOPHARM INC |
| May 15, 2023 | NIH | STTR Phase I Targeting glioblastoma with CM93, a novel EGFR inhibitor with exceptional brain penetration | $400K | CRIMSON BIOPHARM INC with DANA-FARBER CANCER INST |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,339
Awards as PI#1,252
Patents#273
Companies
- CRIMSON BIOPHARM INCLeads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.